[{"indications": "Indications\u00a0type 2 diabetes mellitus in combination with metformin (section 6.1.2.2) when metformin alone inadequate", "name": "NATEGLINIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.1 Drugs used in diabetes", "6.1.2 Antidiabetic drugs", "6.1.2.3 Other antidiabetic drugs", "NATEGLINIDE"], "cautions": "Cautions\u00a0substitute insulin during intercurrent\r\nillness (such as myocardial infarction, coma, infection,\r\nand trauma) and during surgery (omit nateglinide on morning of surgery\r\nand recommence when eating and drinking normally); elderly, debilitated and malnourished\r\npatients; interactions: Appendix 1\r\n(antidiabetics)", "side-effects": "Side-effects\u00a0hypoglycaemia; hypersensitivity reactions including\r\npruritus, rashes and urticaria", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/106130.htm", "doses": ["adult over 18 years, initially\r\n60\u00a0mg 3 times daily within 30 minutes before main meals, adjusted\r\naccording to response up to max. 180\u00a0mg 3 times daily"], "pregnancy": "Pregnancy\u00a0avoid\u2014toxicity in animal studies"}]